|
|
|
|
LEADER |
02362nam a2200445 i 4500 |
001 |
EBC3564286 |
003 |
MiAaPQ |
005 |
20200520144314.0 |
006 |
m o d | |
007 |
cr cnu|||||||| |
008 |
140127t20132013dcuab ob 000 0 eng|d |
020 |
|
|
|z 0309269393 (pbk.)
|
020 |
|
|
|z 9780309269391 (pbk.)
|
020 |
|
|
|a 9780309269407
|q (electronic bk.)
|
035 |
|
|
|a (MiAaPQ)EBC3564286
|
035 |
|
|
|a (Au-PeEL)EBL3564286
|
035 |
|
|
|a (CaPaEBR)ebr10863743
|
035 |
|
|
|a (OCoLC)839275199
|
040 |
|
|
|a MiAaPQ
|b eng
|e rda
|e pn
|c MiAaPQ
|d MiAaPQ
|
050 |
|
4 |
|a HD9665.5
|b .I57 2013
|
110 |
2 |
|
|a Institute of Medicine (U.S.).
|b Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products,
|e issuing body.
|
245 |
1 |
0 |
|a Countering the problem of falsified and substandard drugs /
|c Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health ; Gillian J. Buckley and Lawrence O. Gostin, editors ; Institute of Medicine of the National Academies.
|
264 |
|
1 |
|a Washington, District of Columbia :
|b National Academies Press,
|c [2013]
|
264 |
|
4 |
|c 2013
|
300 |
|
|
|a 1 online resource (375 pages) :
|b illustrations (chiefly color), color maps
|
336 |
|
|
|a text
|2 rdacontent
|
337 |
|
|
|a computer
|2 rdamedia
|
338 |
|
|
|a online resource
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references.
|
588 |
|
|
|a Description based on print version record.
|
590 |
|
|
|a Electronic reproduction. Ann Arbor, MI : ProQuest, 2016. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
|
650 |
|
0 |
|a Pharmaceutical industry
|x Quality control.
|
650 |
|
0 |
|a Fraud
|x Prevention.
|
655 |
|
4 |
|a Electronic books.
|
700 |
1 |
|
|a Buckley, Gillian J.,
|e editor.
|
700 |
1 |
|
|a Gostin, Lawrence O.
|q (Lawrence Ogalthorpe),
|e editor.
|
710 |
2 |
|
|a Institute of Medicine.
|b Board on Global Health,
|e issuing body.
|
776 |
0 |
8 |
|i Print version:
|a Institute of Medicine (U.S.).
|t Countering the problem of falsified and substandard drugs.
|d Washington, District of Columbia : National Academies Press, [2013]
|h xxiv, 351 pages ; 23 cm
|z 9780309269391
|w (DLC)18019897
|
797 |
2 |
|
|a ProQuest (Firm)
|
856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/matrademy/detail.action?docID=3564286
|z Click to View
|